Firstly, they demonstrated that NLRP3 is upregulated in dystrophic mdx TA muscle and in human DMD primary cells, which was abolished with a 24-h adiponectin treatment. The gene discussed is NLRP3; the disease is Duchenne muscular dystrophy.